Glyphosate use has risen 15 fold. 18.9 billion pounds of glyphosate used globally.

toxic chemicalA new study by Charles Benbrook, PH.D, has revealed that the use of has risen almost 15-fold since “Round Ready” genetically engineered crops were introduced in 1996. now accounts for 56% of global used through the use of genetically engineered herbicide-tolerant crops.

The study, published in the journal Environmental Sciences Europe, estimates that 18.9 billion pound of has been used globally with 19% originating from the U.S.

The classification by International Agency for Research on Cancer (IARC) of as a human carcinogen, based on laboratory animal studies, has brought serious human health issues to light.

“My hope is that this paper will stimulate more research on use and human and environmental exposure patterns to increase the chance that scientists will quickly detect any problems that might be triggered, or made worse, by exposure,” said Dr. Benbrook. “The dramatic and rapid growth in overall use of will likely contribute to a host of adverse environmental and public health consequences.”

Global soybean production in 2014 was 315.4 million metric tons (11.6 million bushels), with the U.S. (108 million metric tons), Brazil (94.5 mill. metric tons), and Argentina (56 mill. metric tons) accounting for 82 % of the global harvest.

For human , the U.S. EPA has set ’s daily chronic Reference Dose (cRfD) at 1.75 milligrams per kilogram of bodyweight (mg/kg bodyweight/day). The EU-set cRfD for was recently raised from 0.3 to 0.5 mg/kg/day, 3.5-fold lower than EPA’s. A team of scientists has compiled evidence supporting the need for a fivefold reduction in the EU cRfD to 0.1 mg/kg/day, a level 17-times lower than EPA’s.

The California Office of Environmental Health Hazard Assessment (ORHHA) has announced that will be adding Roundup to it’s state’s list of known carcinogens. A report released in 2015 by the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) specified that the agency intends to list and three other chemicals as a cancer-causing chemicals under California’s Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65).

is one of the most pervasive in use globally and its components have been genetically engineered to be included in herbicide resistant crops. A new study by the International Agency for Research on Cancer (IARC) has released a report classifying it as a carcinogen specifying that that there is sufficient evidence of carcinogenicity based on current existing laboratory studies. IARC’s classification has placed in the “probable” carcinogen 2A group and claims that is not safe as touted by Monsanto who sells the product as Roundup.

The IARC has highlighted that caused DNA and chromosomal damage in and additional epidemiologic studies have found that exposure to is significantly associated with an increased risk of non-Hodgkin’s Lymphoma (NHL).

A new study released by the Center for Biological Diversity, the Center for Environmental Health, El Quinto Sol de America, Californians for Pesticide Reform, the Center for Food Safety and the Pesticide Action Network revealed that more than half of the commercial sprayed in California is applied in the state’s eight most impoverished counties.

The report, titled “Lost in the Mist: How Use Disproportionately Threatens California’s Most Impoverished Counties”, determined that spraying in California occurs in eight counties with a predominantly low income and minority population. Fifty-four percent of all sprayed in California occurs in these counties.

“We’ve uncovered a disturbing trend where poor and minority communities disproportionately live in regions where is sprayed,” said Nathan Donley, Ph.D., a staff scientist with the Center for Biological Diversity. “In high doses is dangerous to people, and California can’t, in good conscience, keep allowing these communities to pay the price for our overreliance on pesticides.”

Previous studies have linked long-term exposure to in drinking water to adverse impacts on health of liver and kidneys. A new study has emerged which has analyzed the rate of chronic disease in the United States and the corresponding use in pesticides. The research findings link the use of to diabetes, obesity, lipoprotein metabolism disorder, Alzheimer’s, senile dementia, Parkinson’s, and autism.

The study highlights the cost associated with chronic disease such as diabetes, estimated at $116 billion dollars in 2007.Estimated costs related to obesity were $147 billion in 2008 and cardiovascular diseases and stroke were $475.3 billion in 2009. Health care expenditures in the US totaled 2.2 trillion dollars in 2007.

The research consisted of searching US government databases for GE , application data and disease epidemiological data. Correlation analyses were then performed on a total of 22 diseases in these time-series data sets. The Pearson correlation coefficients obtained as a result of the study are highly significant (< 10-5) between applications and hypertension (R = 0.923), stroke (R = 0.925), diabetes prevalence (R = 0.971), diabetes incidence (R = 0.935), obesity (R = 0.962), lipoprotein metabolism disorder (R = 0.973), Alzheimer’s (R = 0.917), senile dementia (R = 0.994), Parkinson’s (R = 0.875), (R = 0.828), autism (R = 0.989), inflammatory bowel disease (R = 0.938), intestinal infections (R = 0.974), end stage renal disease (R = 0.975), acute (R = 0.978), cancers of the thyroid (R = 0.988), liver (R = 0.960), bladder (R = 0.981), pancreas (R = 0.918), kidney (R = 0.973) and myeloid leukaemia (R = 0.878). The Pearson correlation coefficients are highly significant (< 10-4) between the percentage of GE and soy planted in the US and hypertension (R = 0.961), stroke (R = 0.983), diabetes prevalence (R = 0.983), diabetes incidence (R = 0.955), obesity (R = 0.962), lipoprotein metabolism disorder (R = 0.955), Alzheimer’s (R = 0.937), Parkinson’s (R = 0.952), (R = 0.876), hepatitis C (R = 0.946), end stage renal disease (R = 0.958), acute (R = 0.967), cancers of the thyroid (R = 0.938), liver (R = 0.911), bladder (R = 0.945), pancreas (R = 0.841), kidney (R = 0.940) and myeloid leukaemia (R = 0.889).

Monsanto filed a complaint against the state's Office of Environmental Health Hazard Assessment (OEHHA) and the agency's acting director, Lauren Zeise, in California state court. The case is Monsanto Company v. Office of Environmental Health Hazard Assessment, et al, case number 16-CECG-00183 in the Superior Court of the State of California, County of Fresno.

"The IARC classification of is inconsistent with the findings of regulatory bodies in the United States and around the world, and it is not a sound basis for any regulatory action," said Phil Miller, Monsanto's vice president of regulatory affairs.

Monsanto's lawsuit argues that listing under Proposition 65, as the state's law is known, based on IARC's classification cedes regulatory authority to an "unelected, undemocratic, unaccountable, and foreign body" that is not subject to oversight by any state or federal entity.


Monsanto sues the State of California. IARC’s cancer classification “unelected, undemocratic, unaccountable, and foreign body”. Foodexposed.

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *